BRIEF-Stemline Therapeutics announces positive FDA meeting, agreement on expedited pathway to full approval of SL-401 in first-line BPDCN

* Stemline Therapeutics announces positive FDA meeting and

agreement on expedited pathway to full approval of SL-401 in

first-line BPDCN

Read more